➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Mallinckrodt
Johnson and Johnson
Moodys
McKinsey

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

Insulin susp isophane recombinant human - Biologic Drug Details


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for insulin susp isophane recombinant human

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Julphar Gulf Pharmaceutical IndustriesPhase 1
Profil Institut für Stoffwechselforschung GmbHPhase 1
Inova Health Care ServicesPhase 4

See all insulin susp isophane recombinant human clinical trials

Patent Text Search: US Patents for insulin susp isophane recombinant human

These patents were identified by searching patent claims

Supplementary Protection Certificates for insulin susp isophane recombinant human

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
04C/020 Belgium ⤷  Try it Free PRODUCT NAME: INSULIN DETEMIR; AUTHORISATION NUMBER AND DATE: 56370 01 20040601
40/2005 Austria ⤷  Try it Free PRODUCT NAME: NOVOMIX 50 - SUSPENSION, ENTHALTEND LÖSLICHES INSULIN ASPART UND PROTAMINKRISTALLISIERTES INSULIN ASPART IM VERHÄLTNIS 50:50
2005 00018 Denmark ⤷  Try it Free PRODUCT NAME: INSULIN GLULISIN
2013 022 Romania ⤷  Try it Free PRODUCT NAME: COMBINATIE DE INSULINA DEGLUDEC SI INSULINA ASPART IN TOATEFORMELE SALE ASA CUM SUNT PROTEJATE IN BREVETUL DEBAZA; NATIONAL AUTHORISATION NUMBER: EU/1/12/806/001,EU/1/12/806/004,EU/1/12/806/005,EU/1/12/806/007,00; DATE OF NATIONAL AUTHORISATION: 20130121; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/12/806/001, EU/1/12/806/004, EU/1/12/806/005, EU/1/12/806/007, 00; DATE OF FIRST AUTHORISATION IN EEA: 20130121
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Boehringer Ingelheim
Express Scripts
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.